Characteristic | NDUOPAP | NCPAP | P value |
---|---|---|---|
Failure in first 72 h, n (%) | 3(4.1%) | 6(8.1%) | 0.494 |
Duration of Noninvasive Respiratory support (hr) (mean± SD) | 39.18±18.14 | 50.12±23.83 | 0.004 |
Duration of oxygen therapy (hr) (mean± SD) | 75.48±26.06 | 107.45±156.06 | 0.034 |
Duration of hospitalization (hr) Mean ± SD) | 495.88±310.11 | 668.08±360.46 | 0.002 |
Pneumothorax, n median (IQR) | 0(0) | 2(2.7) | 0.497 |
IVH, n (%) Grade I & II | 3(4.1) | 5(6.8) | 0.719 |
PDA mild, n (%) | 4(5.4%) | 5(6.8%) | 1 |
PDA moderate, n (%) | 4(5.4) | 3(4.1) | 1 |
BPD, n (%) | 0(0) | 1(1.4) | 0.319 |
Apnea, n (%) | 1(1.4%) | 4(5.4%) | 0.366 |
Deaths, n (%) | 2(2.7%) | 5(6.8%) | 0.442 |
Surfactant First dose, n (%) | 31(41.9%) | 39(52.7%) | 0.042 |
Surfactant Secondary dose, n (%) | 13(17.6%) | 20(27%) | 0.042 |
Surfactant 3 dose, n (%) | 2(2.7%) | 1(1.4%) | 0.042 |